Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 167   

Articles published

PFE 34.10 +0.43 (1.28%)
price chart
Pfizer Inc. (NYSE:PFE) Given Average Rating of “BUY” by Brokerages
Pfizer Inc. (NYSE:PFE) has grabbed the attention from analysts, when it saw a value decrease of 0.15 percent in the last trading session.
Pfizer Updates CHAMPIX To Add New Safety And Efficacy Data In European Union  Benzinga
Pfizer, Inc. (NYSE:PFE) Share Rating Recap  The Post
Pfizer Inc. (NYSE:PFE) Analyst Opinion
Pfizer Inc. (NYSE:PFE)stock is currently trading at about $33.74 and lots of rating firms seem to have a target price set on the stock.
Two Movers inside Analysts Radar: Pfizer, Inc. (NYSE:PFE) , Zoetis Inc ...  Street Updates
Ibm Retirement Fund Decreased Stake in Pfizer INC (NYSE:PFE) by $20.82 ...  CCH Daily News
Pfizer Inc (PFE) Closes 0.21% Down on the Day for May 23
Pfizer Inc currently has a total float of 6.06 billion shares and moves 33.23 million a day, on average. The stock opened at $33.83 on May 23 and traded between a low of $33.65 and a high of $33.91.
Two Movers within Analysts Observation: Pfizer, Inc. (NYSE:PFE) , Mylan N.V ...
Pfizer, Inc. (NYSE:PFE) diminished -0.21%, closing at $33.67 after floating between $33.65 and $33.91. The company has market capitalization of $204.20B.
Pfizer Inc. (NYSE:PFE) & Mylan NV (NASDAQ:MYL) Healthcare Stocks on the Move  Wall Street 24
Healthcare Stocks Latest update: Valeant Pharmaceuticals Intl Inc (NYSE:VRX ...
Shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) dropped -4.59% to $26.21 on Monday. The share price is trading in a range of 26.11 - 27.67 (Price in Dollars).
Pfizer Inc. (PFE) To Acquire Anacor Pharmaceuticals Inc. (ANAC) For $5.2B
American pharmaceutical giant Pfizer announced Monday that it will acquire the California-based Anacor Pharmaceuticals in a deal valued at $5.2 billion.
Pfizer Inc. (PFE) Eyes Next M&A Target After Allergan Mega-Deal Fails  Business Finance News
A Look At All Of Pfizer's Acquisitions Over The Past 2 Years  Benzinga
Pfizer, Inc. (NYSE:PFE): Focus Stock Earnings and Rating Review
Analysts and investors will be intently looking to see if the company meets or beats earnings projections after the next report. Pfizer, Inc. (NYSE:PFE) is slated to next report quarterly earnings results on or around 2016-07-26. In the last report ...
Pfizer, Inc. (NYSE:PFE) Hospira Launches LifeCare PCA 7.0 Infusion System
Pfizer, Inc. (NYSE:PFE) has introduced the very first patient-controlled analgesica (PCA) infusion system that comes along with an electronic medical record (EMR) integration known as the LifeCare PCA 7.0 Infusion System.
Worth Watching Stock's Buzzers: Pfizer Inc. (NYSE:PFE), Huntington ...  NYSE Journal (press release)
Alliancebernstein LP Decreased Stake in Pfizer INC (NYSE:PFE) by $183.92 ...
Alliancebernstein Lp decreased its stake in Pfizer Inc (NYSE:PFE) by 11.45% based on its latest 2016Q1 regulatory filing with the SEC.
Stock on Upward Trend: Pfizer Inc. (NYSE:PFE)
Over the last month, shares of Pfizer Inc. (NYSE:PFE) have moved up steadily. The stock is up 2.11% for that time period, yielding nice profits for investors who are looking to cash in on the short term gains.